Literature DB >> 19412887

Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation.

Reinhard Brunmeir1, Sabine Lagger, Christian Seiser.   

Abstract

During development from the fertilized egg to a multicellular organism, cell fate decisions have to be taken and cell lineage or tissue-specific gene expression patterns are created and maintained. These alterations in gene expression occur in the context of chromatin structure and are controlled by chromatin modifying enzymes. Gene disruption studies in different genetic systems have shown an essential role of various histone deacetylases (HDACs) during early development and cellular differentiation. In this review, we focus on the functions of the class I enzymes HDAC1 and HDAC2 during development in different organisms and summarise the current knowledge about their involvement in neurogenesis, myogenesis, haematopoiesis and epithelial cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412887     DOI: 10.1387/ijdb.082649rb

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  93 in total

1.  Hyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung.

Authors:  Vedang A Londhe; Isaac K Sundar; Benjamin Lopez; Tiffany M Maisonet; Yang Yu; Zubair H Aghai; Irfan Rahman
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

2.  HDAC1, a novel marker for benign teratomas.

Authors:  Elisabeth Simboeck; Luciano Di Croce
Journal:  EMBO J       Date:  2010-12-01       Impact factor: 11.598

3.  Metastasis tumor antigen 2 (MTA2) is involved in proper imprinted expression of H19 and Peg3 during mouse preimplantation development.

Authors:  Pengpeng Ma; Shu Lin; Marisa S Bartolomei; Richard M Schultz
Journal:  Biol Reprod       Date:  2010-08-18       Impact factor: 4.285

Review 4.  Histone Deacetylases in Bone Development and Skeletal Disorders.

Authors:  Elizabeth W Bradley; Lomeli R Carpio; Andre J van Wijnen; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

5.  HDAC Inhibitor Conjugated Polymeric Prodrug Micelles for Doxorubicin Delivery.

Authors:  Suchithra A Senevirathne; Katherine E Washington; Jason B Miller; Michael C Biewer; David Oupicky; Daniel J Siegwart; Mihaela C Stefan
Journal:  J Mater Chem B       Date:  2017-02-20       Impact factor: 6.331

Review 6.  The natural tumor suppressor protein maspin and potential application in non small cell lung cancer.

Authors:  Fulvio Lonardo; Xiaohua Li; Alexander Kaplun; Ayman Soubani; Seema Sethi; Shirish Gadgeel; Shijie Sheng
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

Review 7.  Child health, developmental plasticity, and epigenetic programming.

Authors:  Z Hochberg; R Feil; M Constancia; M Fraga; C Junien; J-C Carel; P Boileau; Y Le Bouc; C L Deal; K Lillycrop; R Scharfmann; A Sheppard; M Skinner; M Szyf; R A Waterland; D J Waxman; E Whitelaw; K Ong; K Albertsson-Wikland
Journal:  Endocr Rev       Date:  2010-10-22       Impact factor: 19.871

8.  Expression of class I histone deacetylases during chick and mouse development.

Authors:  Christina Murko; Sabine Lagger; Marianne Steiner; Christian Seiser; Christian Schoefer; Oliver Pusch
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

9.  Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells.

Authors:  Matthew LeBoeuf; Anne Terrell; Sohum Trivedi; Satrajit Sinha; Jonathan A Epstein; Eric N Olson; Edward E Morrisey; Sarah E Millar
Journal:  Dev Cell       Date:  2010-11-18       Impact factor: 12.270

10.  Overexpression of histone deacetylase 2 predicts unfavorable prognosis in human gallbladder carcinoma.

Authors:  Xilin Du; Huadong Zhao; Li Zang; Nuan Song; Tao Yang; Rui Dong; Jikai Yin; Chengguo Wang; Jianguo Lu
Journal:  Pathol Oncol Res       Date:  2012-12-16       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.